Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for ATRC

Stock Name	AtriCure Inc
Ticker	ATRC(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US04963C2098

Show aggregate ATRC holdings

News associated with ATRC

AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of “Buy” from Brokerages: AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) has been given a consensus recommendation of “Buy” by the nine brokerages that are covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have issued ratings on the stock in the last […] - 2025-08-22 02:26:44
AtriCure, Inc. (NASDAQ:ATRC) Short Interest Up 46.1% in July: AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) saw a significant increase in short interest during the month of July. As of July 31st, there was short interest totaling 2,220,000 shares, anincreaseof46.1% from the July 15th total of 1,520,000 shares. Based on an average daily volume of 546,100 shares, the short-interest ratio is presently 4.1 days. […] - 2025-08-21 05:28:44
XTX Topco Ltd Makes New $526,000 Investment in AtriCure, Inc. (NASDAQ:ATRC): XTX Topco Ltd purchased a new position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the first quarter, Holdings Channel reports. The firm purchased 16,301 shares of the medical device company’s stock, valued at approximately $526,000. A number of other hedge funds also recently bought and sold shares of the business. Hood River […] - 2025-08-07 05:01:01
Mackenzie Financial Corp Increases Position in AtriCure, Inc. (NASDAQ:ATRC): Mackenzie Financial Corp lifted its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 91.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,143 shares of the medical device company’s stock after acquiring an additional 13,929 shares during the quarter. Mackenzie Financial […] - 2025-08-06 05:07:47
AtriCure (NASDAQ:ATRC) Shares Gap Up on Strong Earnings: AtriCure, Inc. (NASDAQ:ATRC – Get Free Report)’s stock price gapped up prior to trading on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $31.73, but opened at $37.70. AtriCure shares last traded at $37.03, with a volume of 594,302 shares traded. The medical device company reported ($0.02) […] - 2025-08-01 02:07:09
Allianz Asset Management GmbH Has $3.96 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC): Allianz Asset Management GmbH lifted its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 22.8% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 122,858 shares of the medical device company’s stock after acquiring an additional 22,838 shares during the period. Allianz Asset Management GmbH owned […] - 2025-07-29 04:44:56
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of “Buy” from Analysts: AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) has been given a consensus recommendation of “Buy” by the nine ratings firms that are covering the stock, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have updated their coverage on the stock […] - 2025-07-28 03:06:51
Mackenzie Financial Corp Takes Position in AtriCure, Inc. (NASDAQ:ATRC): Mackenzie Financial Corp acquired a new position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 15,214 shares of the medical device company’s stock, valued at approximately $465,000. Other institutional investors and hedge funds have also […] - 2025-06-04 05:16:59
AtriCure (NASDAQ:ATRC) Stock Rating Lowered by Wall Street Zen: Wall Street Zen cut shares of AtriCure (NASDAQ:ATRC – Free Report) from a buy rating to a hold rating in a research report released on Sunday morning. A number of other analysts also recently weighed in on ATRC. Piper Sandler upped their target price on shares of AtriCure from $40.00 to $50.00 and gave the […] - 2025-06-02 04:26:45
AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Squarepoint Ops LLC: Squarepoint Ops LLC cut its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 64.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,472 shares of the medical device company’s stock after selling 101,207 shares during the […] - 2025-05-30 05:35:00
State of Wyoming Acquires 446 Shares of AtriCure, Inc. (NASDAQ:ATRC): State of Wyoming boosted its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 21.9% in the 4th quarter, HoldingsChannel reports. The firm owned 2,481 shares of the medical device company’s stock after buying an additional 446 shares during the period. State of Wyoming’s holdings in AtriCure were worth $76,000 at the end […] - 2025-05-29 05:08:55
ProShare Advisors LLC Increases Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC): ProShare Advisors LLC grew its stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 49.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,330 shares of the medical device company’s stock after purchasing an additional 4,385 shares during the quarter. ProShare […] - 2025-05-28 05:13:03
Man Group plc Invests $745,000 in AtriCure, Inc. (NASDAQ:ATRC): Man Group plc purchased a new position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 24,368 shares of the medical device company’s stock, valued at approximately $745,000. Other institutional investors and hedge funds […] - 2025-05-26 05:01:05
AtriCure (NASDAQ:ATRC) Stock Rating Upgraded by Wall Street Zen: AtriCure (NASDAQ:ATRC – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. A number of other analysts have also commented on ATRC. Stifel Nicolaus boosted their price objective on shares of AtriCure from $36.00 to $48.00 and gave […] - 2025-05-26 02:12:50
ATRC Crosses Below Key Moving Average Level: In trading on Friday, shares of AtriCure Inc (Symbol: ATRC) crossed below their 200 day moving average of $32.37, changing hands as low as $31.95 per share. AtriCure Inc shares are currently trading down about 0.8% on the day. The chart below shows the one year performance of - 2025-05-23 12:36:54
Nuveen Asset Management LLC Sells 149,584 Shares of AtriCure, Inc. (NASDAQ:ATRC): Nuveen Asset Management LLC decreased its position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 12.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 1,037,348 shares of the medical device company’s stock after selling 149,584 shares during the quarter. Nuveen Asset Management LLC’s holdings in AtriCure were worth $31,701,000 as of its most recent […] - 2025-05-22 05:58:59
BNP Paribas Financial Markets Has $2.97 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC): BNP Paribas Financial Markets lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 676.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 97,310 shares of the medical device company’s stock after buying an additional 84,776 […] - 2025-05-16 06:02:57
Northern Trust Corp Increases Holdings in AtriCure, Inc. (NASDAQ:ATRC): Northern Trust Corp grew its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 11.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 483,607 shares of the medical device company’s stock after purchasing an additional 50,153 shares during the […] - 2025-05-16 04:38:56
Dimensional Fund Advisors LP Raises Position in AtriCure, Inc. (NASDAQ:ATRC): Dimensional Fund Advisors LP increased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 24.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 700,212 shares of the medical device company’s stock after acquiring an additional 136,015 shares during the quarter. Dimensional Fund Advisors LP’s holdings in AtriCure were worth $21,398,000 […] - 2025-05-08 04:45:00
Barclays PLC Has $2.64 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC): Barclays PLC trimmed its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 33.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 86,541 shares of the medical device company’s stock after selling 42,724 shares during the quarter. Barclays PLC’s holdings in AtriCure were worth […] - 2025-05-01 05:14:58
AtriCure (NASDAQ:ATRC) Trading Up 4.9% After Better-Than-Expected Earnings: AtriCure, Inc. (NASDAQ:ATRC – Get Free Report)’s share price traded up 4.9% on Tuesday following a stronger than expected earnings report. The company traded as high as $35.19 and last traded at $35.31. 373,568 shares were traded during mid-day trading, a decline of 43% from the average session volume of 654,896 shares. The stock had […] - 2025-05-01 02:40:58
Envestnet Asset Management Inc. Cuts Position in AtriCure, Inc. (NASDAQ:ATRC): Envestnet Asset Management Inc. decreased its stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 4.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 46,086 shares of the medical device company’s stock after selling 2,104 shares during the period. Envestnet Asset Management […] - 2025-04-30 04:42:56
Raymond James Financial Inc. Acquires Shares of 121,591 AtriCure, Inc. (NASDAQ:ATRC): Raymond James Financial Inc. acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 121,591 shares of the medical device company’s stock, valued at approximately $3,716,000. Several other hedge […] - 2025-04-27 06:26:45
AtriCure (NASDAQ:ATRC) and KORU Medical Systems (NASDAQ:KRMD) Financial Survey: AtriCure (NASDAQ:ATRC – Get Free Report) and KORU Medical Systems (NASDAQ:KRMD – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends. Valuation and Earnings This table compares AtriCure […] - 2025-04-22 02:50:55
Townsquare Capital LLC Decreases Stake in AtriCure, Inc. (NASDAQ:ATRC): Townsquare Capital LLC decreased its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 4.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 16,138 shares of the medical device company’s stock after selling 789 shares during the period. Townsquare Capital LLC’s holdings in AtriCure were worth $493,000 […] - 2025-04-21 05:26:42
JPMorgan Chase & Co. Buys 110,039 Shares of AtriCure, Inc. (NASDAQ:ATRC): JPMorgan Chase & Co. increased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 43.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 365,183 shares of the medical device company’s stock after acquiring an additional 110,039 shares during the quarter. JPMorgan Chase & Co.’s holdings in AtriCure were worth $11,160,000 […] - 2025-04-14 04:39:04
Corebridge Financial Inc. Reduces Holdings in AtriCure, Inc. (NASDAQ:ATRC): Corebridge Financial Inc. lowered its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 7.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,535 shares of the medical device company’s stock after selling 1,776 shares during the quarter. Corebridge Financial Inc.’s […] - 2025-04-07 04:32:51
Analysts Set AtriCure, Inc. (NASDAQ:ATRC) Target Price at $51.56: Shares of AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) have earned an average recommendation of “Buy” from the nine analysts that are currently covering the firm, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued ratings on the stock in the […] - 2025-03-28 04:56:46
Needham & Company LLC Reaffirms “Buy” Rating for AtriCure (NASDAQ:ATRC): Needham & Company LLC reaffirmed their buy rating on shares of AtriCure (NASDAQ:ATRC – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $51.00 price target on the medical device company’s stock. Several other analysts also recently commented on ATRC. JMP Securities reaffirmed a “market outperform” rating and […] - 2025-03-24 04:34:46
Analysts See 32% Gains Ahead For The Holdings of ESML: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-12 09:42:28

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc ATRC holdings

Date	Number of ATRC Shares Held	Base Market Value of ATRC Shares	Local Market Value of ATRC Shares	Change in ATRC Shares Held	Change in ATRC Base Value	Current Price per ATRC Share Held	Previous Price per ATRC Share Held
2025-09-26 (Friday)	36,962	USD 1,301,062	USD 1,301,062
2025-09-25 (Thursday)	36,962	USD 1,294,779	USD 1,294,779	0	USD -39,180	USD 35.03	USD 36.09
2025-09-24 (Wednesday)	36,962	USD 1,333,959	USD 1,333,959
2025-09-17 (Wednesday)	36,722	USD 1,285,637	USD 1,285,637	0	USD -34,886	USD 35.01	USD 35.96
2025-09-16 (Tuesday)	36,722	USD 1,320,523	USD 1,320,523
2025-09-12 (Friday)	36,482	USD 1,279,424	USD 1,279,424
2025-09-11 (Thursday)	36,482	USD 1,370,264	USD 1,370,264	480	USD 74,192	USD 37.56	USD 36

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ATRC by Blackrock for IE00B3VWM098

Show aggregate share trades of ATRC

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-11 BUY 480 37.560* 34.19
2025-08-21 SELL -120 35.730* 34.19 Profit of 4,102 on sale
2025-07-31 BUY 357 35.100* 34.17
2025-06-30 SELL -238 32.770* 34.55 Profit of 8,223 on sale
2025-06-25 SELL -119 32.270* 34.59 Profit of 4,117 on sale
2025-06-20 SELL -240 31.400* 34.65 Profit of 8,316 on sale
2025-05-30 SELL -12,149 34.570* 34.80 Profit of 422,808 on sale
2025-05-23 BUY 161 32.710* 34.86
2025-05-19 SELL -161 32.400* 34.92 Profit of 5,622 on sale
2025-05-15 SELL -483 32.300* 34.96 Profit of 16,887 on sale
2025-05-12 SELL -161 31.810* 35.05 Profit of 5,642 on sale
2025-05-09 SELL -161 30.990* 35.08 Profit of 5,648 on sale
2025-04-30 SELL -161 29.910* 35.43 Profit of 5,705 on sale
2025-04-24 SELL -322 33.750* 35.50 Profit of 11,430 on sale
2025-04-17 SELL -161 32.010* 35.68 Profit of 5,744 on sale
2025-04-15 SELL -483 32.360* 35.75 Profit of 17,269 on sale
2025-04-14 SELL -486 32.620* 35.79 Profit of 17,393 on sale
2025-04-09 SELL -648 33.100* 35.91 Profit of 23,269 on sale
2025-04-07 SELL -1,134 31.590* 36.02 Profit of 40,847 on sale
2025-04-04 SELL -1,620 31.310* 36.08 Profit of 58,443 on sale
2025-03-31 BUY 162 32.260* 36.18
2025-03-19 SELL -324 34.820* 36.40 Profit of 11,794 on sale
2025-03-14 SELL -972 33.310* 36.52 Profit of 35,495 on sale
2025-03-13 SELL -324 32.760* 36.57 Profit of 11,849 on sale
2025-03-12 SELL -5,508 32.690* 36.63 Profit of 201,743 on sale
2025-03-07 SELL -324 34.520* 36.75 Profit of 11,906 on sale
2025-03-06 SELL -486 36.250* 36.75 Profit of 17,863 on sale
2025-03-03 SELL -162 38.960* 36.68 Profit of 5,942 on sale
2025-02-28 SELL -972 38.740* 36.64 Profit of 35,619 on sale
2025-02-26 SELL -162 39.930* 36.56 Profit of 5,922 on sale
2025-02-25 SELL -486 39.430* 36.51 Profit of 17,743 on sale
2025-02-18 BUY 810 38.220* 36.29
2025-02-13 BUY 162 39.590* 36.04
2025-02-12 BUY 162 42.360* 35.91
2025-02-11 BUY 486 41.510* 35.80
2025-02-06 BUY 1,458 40.960* 35.43
2025-01-27 BUY 162 40.840* 34.24
2024-12-30 BUY 810 30.250* 34.09
2024-12-06 BUY 648 34.250* 34.10
2024-12-05 BUY 162 34.110* 34.10
2024-12-04 BUY 810 36.310* 34.02
2024-11-29 BUY 810 36.160* 33.73
2024-11-27 BUY 648 36.170* 33.51
2024-11-26 BUY 162 35.790* 33.41
2024-11-25 BUY 6,885 36.010* 33.29
2024-11-21 BUY 705 35.680* 33.03
2024-11-20 BUY 423 36.030* 32.87
2024-11-18 BUY 1,692 34.720* 32.53
2024-11-12 BUY 1,128 36.630* 32.26
2024-11-08 BUY 705 37.450* 31.89
2024-11-07 BUY 2,115 37.360* 31.47
2024-11-06 BUY 282 37.620* 30.96
2024-10-31 BUY 141 33.180* 29.46
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-11	BUY	480	37.560*	34.19
2025-08-21	SELL	-120	35.730*	34.19 Profit of 4,102 on sale
2025-07-31	BUY	357	35.100*	34.17
2025-06-30	SELL	-238	32.770*	34.55 Profit of 8,223 on sale
2025-06-25	SELL	-119	32.270*	34.59 Profit of 4,117 on sale
2025-06-20	SELL	-240	31.400*	34.65 Profit of 8,316 on sale
2025-05-30	SELL	-12,149	34.570*	34.80 Profit of 422,808 on sale
2025-05-23	BUY	161	32.710*	34.86
2025-05-19	SELL	-161	32.400*	34.92 Profit of 5,622 on sale
2025-05-15	SELL	-483	32.300*	34.96 Profit of 16,887 on sale
2025-05-12	SELL	-161	31.810*	35.05 Profit of 5,642 on sale
2025-05-09	SELL	-161	30.990*	35.08 Profit of 5,648 on sale
2025-04-30	SELL	-161	29.910*	35.43 Profit of 5,705 on sale
2025-04-24	SELL	-322	33.750*	35.50 Profit of 11,430 on sale
2025-04-17	SELL	-161	32.010*	35.68 Profit of 5,744 on sale
2025-04-15	SELL	-483	32.360*	35.75 Profit of 17,269 on sale
2025-04-14	SELL	-486	32.620*	35.79 Profit of 17,393 on sale
2025-04-09	SELL	-648	33.100*	35.91 Profit of 23,269 on sale
2025-04-07	SELL	-1,134	31.590*	36.02 Profit of 40,847 on sale
2025-04-04	SELL	-1,620	31.310*	36.08 Profit of 58,443 on sale
2025-03-31	BUY	162	32.260*	36.18
2025-03-19	SELL	-324	34.820*	36.40 Profit of 11,794 on sale
2025-03-14	SELL	-972	33.310*	36.52 Profit of 35,495 on sale
2025-03-13	SELL	-324	32.760*	36.57 Profit of 11,849 on sale
2025-03-12	SELL	-5,508	32.690*	36.63 Profit of 201,743 on sale
2025-03-07	SELL	-324	34.520*	36.75 Profit of 11,906 on sale
2025-03-06	SELL	-486	36.250*	36.75 Profit of 17,863 on sale
2025-03-03	SELL	-162	38.960*	36.68 Profit of 5,942 on sale
2025-02-28	SELL	-972	38.740*	36.64 Profit of 35,619 on sale
2025-02-26	SELL	-162	39.930*	36.56 Profit of 5,922 on sale
2025-02-25	SELL	-486	39.430*	36.51 Profit of 17,743 on sale
2025-02-18	BUY	810	38.220*	36.29
2025-02-13	BUY	162	39.590*	36.04
2025-02-12	BUY	162	42.360*	35.91
2025-02-11	BUY	486	41.510*	35.80
2025-02-06	BUY	1,458	40.960*	35.43
2025-01-27	BUY	162	40.840*	34.24
2024-12-30	BUY	810	30.250*	34.09
2024-12-06	BUY	648	34.250*	34.10
2024-12-05	BUY	162	34.110*	34.10
2024-12-04	BUY	810	36.310*	34.02
2024-11-29	BUY	810	36.160*	33.73
2024-11-27	BUY	648	36.170*	33.51
2024-11-26	BUY	162	35.790*	33.41
2024-11-25	BUY	6,885	36.010*	33.29
2024-11-21	BUY	705	35.680*	33.03
2024-11-20	BUY	423	36.030*	32.87
2024-11-18	BUY	1,692	34.720*	32.53
2024-11-12	BUY	1,128	36.630*	32.26
2024-11-08	BUY	705	37.450*	31.89
2024-11-07	BUY	2,115	37.360*	31.47
2024-11-06	BUY	282	37.620*	30.96
2024-10-31	BUY	141	33.180*	29.46

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ATRC

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	75,764	0	170,365	44.5%
2025-09-18	68,150	17	148,539	45.9%
2025-09-17	48,791	0	104,898	46.5%
2025-09-16	147,271	0	190,380	77.4%
2025-09-15	233,478	0	319,066	73.2%
2025-09-12	193,594	0	286,138	67.7%
2025-09-11	256,897	0	327,489	78.4%
2025-09-10	112,455	30	233,609	48.1%
2025-09-09	111,431	0	139,764	79.7%
2025-09-08	71,626	0	145,780	49.1%
2025-09-05	45,694	0	89,387	51.1%
2025-09-04	52,064	0	96,301	54.1%
2025-09-03	135,433	0	192,545	70.3%
2025-09-02	107,759	1,850	176,495	61.1%
2025-08-29	55,705	0	95,376	58.4%
2025-08-28	58,317	0	91,024	64.1%
2025-08-27	25,898	0	58,260	44.5%
2025-08-26	75,103	0	101,685	73.9%
2025-08-25	99,545	0	129,039	77.1%
2025-08-22	156,328	0	201,036	77.8%
2025-08-21	60,501	0	82,918	73.0%
2025-08-20	82,638	0	129,298	63.9%
2025-08-19	146,235	0	190,741	76.7%
2025-08-18	107,695	0	175,576	61.3%
2025-08-15	73,277	0	113,494	64.6%
2025-08-14	101,489	0	146,417	69.3%
2025-08-13	92,778	0	135,205	68.6%
2025-08-12	63,361	2	182,030	34.8%
2025-08-11	101,105	1,225	267,497	37.8%
2025-08-08	66,584	0	127,311	52.3%
2025-08-07	109,839	0	173,947	63.1%
2025-08-06	155,847	0	248,439	62.7%
2025-08-05	174,601	0	279,099	62.6%
2025-08-04	310,759	0	385,352	80.6%
2025-08-01	162,340	600	255,821	63.5%
2025-07-31	172,073	0	285,817	60.2%
2025-07-30	845,185	2,557	1,422,495	59.4%
2025-07-29	132,608	0	284,229	46.7%
2025-07-28	272,580	0	451,799	60.3%
2025-07-25	106,898	3	202,926	52.7%
2025-07-24	66,169	0	155,270	42.6%
2025-07-23	113,125	0	207,978	54.4%
2025-07-22	95,307	0	153,047	62.3%
2025-07-21	76,931	0	130,826	58.8%
2025-07-18	64,716	0	97,343	66.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE